TCL1	B-DNA
oncogene	I-DNA
expression	O
in	O
AIDS-related	O
lymphomas	O
and	O
lymphoid	O
tissues	O
.	O

AIDS-related	O
non-Hodgkin	O
's	O
lymphoma	O
(	O
AIDS	O
NHL	O
)	O
comprises	O
a	O
diverse	O
and	O
heterogeneous	O
group	O
of	O
high-grade	O
B	O
cell	O
tumors	O
.	O

Certain	O
classes	O
of	O
AIDS	O
NHL	O
are	O
associated	O
with	O
alterations	O
in	O
oncogenes	B-DNA
or	O
tumor-suppressor	B-DNA
genes	I-DNA
or	O
infections	O
by	O
oncogenic	O
herpesviruses	O
.	O

However	O
,	O
the	O
clinically	O
significant	O
class	O
of	O
AIDS	O
NHL	O
designated	O
immunoblastic	O
lymphoma	O
plasmacytoid	O
(	O
AIDS	O
IBLP	O
)	O
lacks	O
any	O
consistent	O
genetic	O
alterations	O
.	O

We	O
identified	O
the	O
TCL1	B-DNA
oncogene	I-DNA
from	O
a	O
set	O
of	O
AIDS	B-DNA
IBLP-associated	I-DNA
cDNA	I-DNA
fragments	I-DNA
generated	O
by	O
subtractive	O
hybridization	O
with	O
non-AIDS	O
IBLP	O
.	O

Aberrant	O
TCL1	B-protein
expression	O
has	O
been	O
implicated	O
in	O
T	O
cell	O
leukemia/lymphoma	O
development	O
,	O
and	O
its	O
expression	O
also	O
has	O
been	O
seen	O
in	O
many	O
established	O
B	B-cell_line
cell	I-cell_line
tumor	I-cell_line
lines	I-cell_line
.	O

However	O
,	O
TCL1	B-protein
expression	O
has	O
not	O
been	O
reported	O
in	O
AIDS	O
NHL	O
.	O

We	O
find	O
that	O
TCL1	B-protein
is	O
expressed	O
in	O
the	O
majority	O
of	O
AIDS	O
IBLP	O
tumors	O
examined	O
.	O

TCL1	B-protein
protein	O
expression	O
is	O
restricted	O
to	O
tumor	O
cells	O
in	O
AIDS	O
IBLP	O
tissue	O
samples	O
analyzed	O
with	O
immunohistochemical	O
staining	O
.	O

Hyperplastic	O
lymph	O
node	O
and	O
tonsil	O
also	O
exhibit	O
strong	O
TCL1	B-protein
protein	O
expression	O
in	O
mantle	B-cell_type
zone	I-cell_type
B	I-cell_type
cells	I-cell_type
and	O
in	O
rare	O
interfollicular	B-cell_type
zone	I-cell_type
cells	I-cell_type
,	O
whereas	O
follicle-center	B-cell_type
B	I-cell_type
cells	I-cell_type
(	O
centroblasts	B-cell_type
and	O
centrocytes	B-cell_type
)	O
show	O
weaker	O
expression	O
.	O

These	O
results	O
establish	O
TCL1	B-protein
as	O
the	O
most	O
prevalent	O
of	O
all	O
of	O
the	O
surveyed	O
oncogenes	B-DNA
associated	O
with	O
AIDS	O
IBLP	O
.	O

They	O
also	O
indicate	O
that	O
abundant	O
TCL1	B-protein
expression	O
in	O
quiescent	B-cell_type
mantle	I-cell_type
zone	I-cell_type
B	I-cell_type
cells	I-cell_type
is	O
down-regulated	O
in	O
activated	O
germinal	B-cell_type
center	I-cell_type
follicular	I-cell_type
B	I-cell_type
cells	I-cell_type
in	O
parallel	O
to	O
the	O
known	O
expression	O
pattern	O
of	O
BCL-2	B-protein
.	O

High-level	O
expression	O
in	O
nonproliferating	B-cell_type
B	I-cell_type
cells	I-cell_type
suggests	O
that	O
TCL1	B-protein
may	O
function	O
in	O
protecting	O
naive	B-cell_type
preactivated	I-cell_type
B	I-cell_type
cells	I-cell_type
from	O
apoptosis	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

96	NULL
,	NULL
pp	NULL
.	NULL

9809-9814	NULL
,	NULL
August	NULL
1999	NULL
Medical	NULL
Sciences	NULL
TCL1	NULL
oncogene	NULL
expression	NULL
in	NULL
AIDS-related	NULL
lymphomas	NULL
and	NULL
lymphoid	NULL
tissues	NULL
MicHaEL	NULL
MIcHaEL	NULL
A.	NULL
DamoRE**	NULL
,	NULL
Gira	NULL
G.	NULL
SULURT	NULL
,	NULL
DEvIN	NULL
E.	NULL
TUuRNER*	NULL
,	NULL
MaRc-HENRI	NULL
STERN	NULL
)	NULL
,	NULL
JONATHAN	NULL
W	NULL
.	NULL

Saip	NULL
?	NULL

,	NULL
CHRISTOPHER	NULL
T	NULL
.	NULL

DENNY	NULL
!	NULL

!	NULL

,	NULL
anD	NULL
RANDOLPH	NULL
WALL	NULL
*Molecular	NULL
Biology	NULL
Institute	NULL
,	NULL
*Department	NULL
of	NULL
Pathology	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
#	NULL
Jonsson	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Division	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
Gwynne	NULL
Hazen	NULL
Cherry	NULL
Memorial	NULL
Laboratories	NULL
,	NULL
and	NULL
**Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90095	NULL
;	NULL
and	NULL
``	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
U462	NULL
,	NULL
Hopital	NULL
Saint	NULL
Louis	NULL
,	NULL
75475	NULL
Paris	NULL
Cedex	NULL
10	NULL
,	NULL
France	NULL
Communicated	NULL
by	NULL
Owen	NULL
N.	NULL
Witte	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
,	NULL
June	NULL
25	NULL
,	NULL
1999	NULL
(	NULL
received	NULL
for	NULL
review	NULL
May	NULL
17	NULL
,	NULL
1999	NULL
)	NULL
ABSTRACT	NULL
AIDS-related	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
(	NULL
AIDS	NULL
NHL	NULL
)	NULL
comprises	NULL
a	NULL
diverse	NULL
and	NULL
heterogeneous	NULL
group	NULL
of	NULL
high-grade	NULL
B	NULL
cell	NULL
tumors	NULL
.	NULL

Certain	NULL
classes	NULL
of	NULL
AIDS	NULL
NHL	NULL
are	NULL
associated	NULL
with	NULL
alterations	NULL
in	NULL
oncogenes	NULL
or	NULL
tumor-suppressor	NULL
genes	NULL
or	NULL
infections	NULL
by	NULL
oncogenic	NULL
herpesviruses	NULL
.	NULL

However	NULL
,	NULL
the	NULL
clinically	NULL
significant	NULL
class	NULL
of	NULL
AIDS	NULL
NHL	NULL
designated	NULL
immunoblastic	NULL
lymphoma	NULL
plasmacytoid	NULL
(	NULL
AIDS	NULL
IBLP	NULL
)	NULL
lacks	NULL
any	NULL
consistent	NULL
genetic	NULL
alterations	NULL
.	NULL

We	NULL
identified	NULL
the	NULL
TCLI	NULL
oncogene	NULL
from	NULL
a	NULL
set	NULL
of	NULL
AIDS	NULL
IBLP-associated	NULL
cDNA	NULL
fragments	NULL
generated	NULL
by	NULL
subtractive	NULL
hybridization	NULL
with	NULL
non-AIDS	NULL
IBLP	NULL
.	NULL

Aberrant	NULL
TCL1	NULL
expression	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
development	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
also	NULL
has	NULL
been	NULL
seen	NULL
in	NULL
many	NULL
established	NULL
B	NULL
cell	NULL
tumor	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
TCLI	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
in	NULL
AIDS	NULL
NHL	NULL
.	NULL

We	NULL
find	NULL
that	NULL
TCL1	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
AIDS	NULL
IBLP	NULL
tumors	NULL
examined	NULL
.	NULL

TCL1	NULL
protein	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
tumor	NULL
cells	NULL
in	NULL
AIDS	NULL
IBLP	NULL
tissue	NULL
samples	NULL
analyzed	NULL
with	NULL
immunohistochemical	NULL
staining	NULL
.	NULL

Hyperplastic	NULL
lymph	NULL
node	NULL
and	NULL
tonsil	NULL
also	NULL
exhibit	NULL
strong	NULL
TCL1	NULL
protein	NULL
expression	NULL
in	NULL
mantle	NULL
zone	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
rare	NULL
interfollicular	NULL
zone	NULL
cells	NULL
,	NULL
whereas	NULL
follicle-center	NULL
B	NULL
cells	NULL
(	NULL
centroblasts	NULL
and	NULL
centrocytes	NULL
)	NULL
show	NULL
weaker	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
establish	NULL
TCLJ	NULL
as	NULL
the	NULL
most	NULL
prevalent	NULL
of	NULL
all	NULL
of	NULL
the	NULL
surveyed	NULL
oncogenes	NULL
associated	NULL
with	NULL
AIDS	NULL
IBLP	NULL
.	NULL

They	NULL
also	NULL
indicate	NULL
that	NULL
abundant	NULL
TCL1	NULL
expression	NULL
in	NULL
quiescent	NULL
mantle	NULL
zone	NULL
B	NULL
cells	NULL
is	NULL
down-regulated	NULL
in	NULL
activated	NULL
germinal	NULL
center	NULL
follicular	NULL
B	NULL
cells	NULL
in	NULL
parallel	NULL
to	NULL
the	NULL
known	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-2	NULL
.	NULL

High-level	NULL
expression	NULL
in	NULL
nonproliferating	NULL
B	NULL
cells	NULL
suggests	NULL
that	NULL
TCL1	NULL
may	NULL
function	NULL
in	NULL
protecting	NULL
naive	NULL
preac-tivated	NULL
B	NULL
cells	NULL
from	NULL
apoptosis	NULL
.	NULL

AIDS-related	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
(	NULL
AIDS	NULL
NHL	NULL
)	NULL
occurs	NULL
in	NULL
up	NULL
to	NULL
10	NULL
%	NULL
of	NULL
HIV-infected	NULL
individuals	NULL
who	NULL
have	NULL
moderate	NULL
to	NULL
severe	NULL
immunodeficiency	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

These	NULL
lymphomas	NULL
are	NULL
biologically	NULL
and	NULL
genetically	NULL
heterogeneous	NULL
,	NULL
are	NULL
derived	NULL
from	NULL
germinal	NULL
center	NULL
or	NULL
postgerminal	NULL
center	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
are	NULL
classified	NULL
according	NULL
to	NULL
body	NULL
location	NULL
and	NULL
histologic	NULL
criteria	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

4-7	NULL
)	NULL
.	NULL

Certain	NULL
AIDS	NULL
NHL	NULL
classes	NULL
are	NULL
associated	NULL
with	NULL
specific	NULL
oncogenic	NULL
lesions	NULL
or	NULL
viral	NULL
involvement	NULL
.	NULL

For	NULL
example	NULL
,	NULL
AIDS-related	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
usually	NULL
contain	NULL
activating	NULL
c-MYC	NULL
translocations	NULL
,	NULL
whereas	NULL
AIDS-related	NULL
pri-mary-effusion	NULL
lymphoma	NULL
consistently	NULL
contain	NULL
human	NULL
herpesvirus-8	NULL
(	NULL
8-24	NULL
)	NULL
.	NULL

AIDS	NULL
diffuse	NULL
large	NULL
B	NULL
cell	NULL
lymphoma	NULL
accounts	NULL
for	NULL
70	NULL
%	NULL
of	NULL
systemic	NULL
lymphomas	NULL
and	NULL
is	NULL
the	NULL
second	NULL
most	NULL
common	NULL
type	NULL
of	NULL
cancer	NULL
after	NULL
Kaposi	NULL
's	NULL
sarcoma	NULL
in	NULL
AIDS	NULL
patients	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Systemic	NULL
AIDS	NULL
diffuse	NULL
large	NULL
B	NULL
cell	NULL
lymphoma	NULL
are	NULL
further	NULL
classified	NULL
into	NULL
two	NULL
subclasses	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
27-29	NULL
)	NULL
.	NULL

AIDS	NULL
large	NULL
noncleaved-cell	NULL
lymphoma	NULL
is	NULL
postulated	NULL
to	NULL
originate	NULL
from	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
and	NULL
often	NULL
exhibits	NULL
dysregulated	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

9809	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protooncogene	NULL
because	NULL
of	NULL
chromosomal	NULL
translocations	NULL
or	NULL
promoter	NULL
mutations	NULL
.	NULL

AIDS	NULL
immunoblastic	NULL
lymphoma	NULL
plasmacytoid	NULL
(	NULL
AIDS	NULL
IBLP	NULL
)	NULL
is	NULL
thought	NULL
to	NULL
derive	NULL
from	NULL
postgerminal	NULL
center	NULL
B	NULL
cells	NULL
and	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
any	NULL
predominant	NULL
genetic	NULL
alteration	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

AIDS	NULL
IBLP	NULL
are	NULL
monoclonal	NULL
tumors	NULL
that	NULL
usually	NULL
contain	NULL
Epstein-Barr	NULL
virus	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
are	NULL
not	NULL
simply	NULL
Epstein-Barr	NULL
virus-driven	NULL
polyclonal	NULL
proliferations	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
any	NULL
consistently	NULL
associated	NULL
oncogene	NULL
involvement	NULL
in	NULL
AIDS	NULL
IBLP	NULL
strongly	NULL
suggests	NULL
that	NULL
these	NULL
tumors	NULL
arise	NULL
through	NULL
novel	NULL
patterns	NULL
of	NULL
dysregulated	NULL
gene	NULL
expression	NULL
(	NULL
7	NULL
,	NULL
15	NULL
,	NULL
32	NULL
)	NULL
.	NULL

We	NULL
sought	NULL
to	NULL
identify	NULL
differentially	NULL
expressed	NULL
genes	NULL
in	NULL
AIDS	NULL
IBLP	NULL
patient	NULL
samples	NULL
versus	NULL
non-AIDS	NULL
lymphoma	NULL
samples	NULL
by	NULL
using	NULL
suppression	NULL
subtractive	NULL
hybridizations	NULL
(	NULL
SSH	NULL
)	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Large	NULL
cell	NULL
lymphomas	NULL
with	NULL
immunoblastic/plasmacytoid	NULL
features	NULL
consistent	NULL
with	NULL
postgerminal	NULL
center	NULL
derivations	NULL
(	NULL
IBLP	NULL
)	NULL
were	NULL
selected	NULL
for	NULL
these	NULL
subtractions	NULL
from	NULL
HIV-infected	NULL
or	NULL
uninfected	NULL
patient	NULL
samples	NULL
.	NULL

The	NULL
TCLI	NULL
oncogene	NULL
was	NULL
identified	NULL
among	NULL
multiple	NULL
differentially	NULL
expressed	NULL
genes	NULL
isolated	NULL
from	NULL
AIDS	NULL
IBLP	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

TCL1	NULL
is	NULL
developmentally	NULL
regulated	NULL
and	NULL
is	NULL
normally	NULL
expressed	NULL
in	NULL
fetal	NULL
thymocytes	NULL
,	NULL
in	NULL
bone	NULL
marrow	NULL
pre-B	NULL
and	NULL
immature	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
weakly	NULL
in	NULL
CD19*	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Abnormal	NULL
TCLI	NULL
expression	NULL
caused	NULL
by	NULL
chromosomal	NULL
translocations	NULL
or	NULL
inversions	NULL
near	NULL
T	NULL
cell	NULL
receptor-enhancer	NULL
elements	NULL
have	NULL
been	NULL
previously	NULL
demonstrated	NULL
in	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
(	NULL
35-39	NULL
)	NULL
.	NULL

Continuous	NULL
tissue-specific	NULL
expression	NULL
of	NULL
TCL	NULL
]	NULL
also	NULL
caused	NULL
transgenic	NULL
mice	NULL
to	NULL
develop	NULL
a	NULL
polyclonal	NULL
T	NULL
cell	NULL
expansion	NULL
with	NULL
subsequent	NULL
progression	NULL
to	NULL
T	NULL
cell	NULL
leukemia	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Widely	NULL
variable	NULL
levels	NULL
of	NULL
TCL1	NULL
expression	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
many	NULL
established	NULL
B	NULL
lymphoblastoid	NULL
and	NULL
B	NULL
cell	NULL
tumor	NULL
lines	NULL
.	NULL

The	NULL
combined	NULL
results	NULL
of	NULL
several	NULL
studies	NULL
showed	NULL
that	NULL
most	NULL
immortalized	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
10/12	NULL
)	NULL
as	NULL
well	NULL
as	NULL
B	NULL
cell	NULL
tumor	NULL
lines	NULL
established	NULL
from	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
15/18	NULL
)	NULL
,	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
9/11	NULL
)	NULL
,	NULL
and	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
(	NULL
8/9	NULL
)	NULL
expressed	NULL
TCL1	NULL
(	NULL
40-42	NULL
)	NULL
.	NULL

TCL1	NULL
expression	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
myeloma	NULL
cell	NULL
lines	NULL
(	NULL
0/9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
findings	NULL
on	NULL
cell	NULL
lines	NULL
,	NULL
TCLI	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
in	NULL
primary	NULL
B	NULL
lymphoid	NULL
tumors	NULL
,	NULL
including	NULL
AIDS-related	NULL
B	NULL
cell	NULL
malignancies	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
levels	NULL
of	NULL
TCL1	NULL
protein	NULL
expression	NULL
in	NULL
AIDS	NULL
IBLP	NULL
samples	NULL
with	NULL
the	NULL
normal	NULL
pattern	NULL
of	NULL
expression	NULL
in	NULL
hyperplastic	NULL
lymph	NULL
node	NULL
(	NULL
HYP	NULL
)	NULL
suggests	NULL
that	NULL
TCLI	NULL
is	NULL
aberrantly	NULL
regulated	NULL
and	NULL
over-expressed	NULL
in	NULL
many	NULL
AIDS	NULL
IBLP	NULL
tumors	NULL
.	NULL

Up-regulation	NULL
of	NULL
TCL	NULL
I	NULL
in	NULL
AIDS	NULL
IBLP	NULL
can	NULL
not	NULL
occur	NULL
by	NULL
the	NULL
same	NULL
chromosomal	NULL
alterations	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
because	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
loci	NULL
are	NULL
transcriptionally	NULL
silent	NULL
in	NULL
normal	NULL
and	NULL
malignant	NULL
B	NULL
cells	NULL
.	NULL

Abbreviations	NULL
:	NULL
NHL	NULL
,	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
;	NULL
IBLP	NULL
,	NULL
immunoblastic	NULL
lymphoma	NULL
plasmacytoid	NULL
;	NULL
HYP	NULL
,	NULL
hyperplastic	NULL
lymph	NULL
node	NULL
;	NULL
SSH	NULL
,	NULL
sup	NULL
gression	NULL
subtractive	NULL
hybridization	NULL
;	NULL
DRC	NULL
,	NULL
dendritic	NULL
reticulum	NULL
cell	NULL
.	NULL

To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

E-mail	NULL
:	NULL
mteitell	NULL
@	NULL
ucla.edu	NULL
.	NULL

9810	NULL
Medical	NULL
Sciences	NULL
:	NULL
Teitell	NULL
et	NULL
al	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patient	NULL
Samples	NULL
,	NULL
cDNA	NULL
Manufacture	NULL
,	NULL
and	NULL
Subtractions	NULL
.	NULL

Fresh-frozen	NULL
patient	NULL
samples	NULL
were	NULL
derived	NULL
from	NULL
HIV-infected	NULL
and	NULL
uninfected	NULL
individuals	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
tissues	NULL
are	NULL
part	NULL
of	NULL
a	NULL
catalogued	NULL
bank	NULL
of	NULL
750	NULL
AIDS-associated	NULL
malignancies	NULL
and	NULL
related	NULL
non-AIDS	NULL
tissue	NULL
samples	NULL
maintained	NULL
at	NULL
UCLA	NULL
.	NULL

Eighty	NULL
of	NULL
the	NULL
AIDS	NULL
NHL	NULL
samples	NULL
in	NULL
this	NULL
bank	NULL
have	NULL
been	NULL
extensively	NULL
characterized	NULL
for	NULL
known	NULL
oncogenes	NULL
,	NULL
tumor-suppressor	NULL
genes	NULL
,	NULL
and	NULL
viral	NULL
involvement	NULL
.	NULL

Subtraction	NULL
sample	NULL
AIDS	NULL
IBLP	NULL
1	NULL
was	NULL
chosen	NULL
from	NULL
these	NULL
characterized	NULL
tumor	NULL
samples	NULL
based	NULL
on	NULL
the	NULL
demonstrated	NULL
absence	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
herpesvirus-8	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
oncogenic	NULL
mutations	NULL
or	NULL
alterations	NULL
in	NULL
p53	NULL
,	NULL
RAS	NULL
,	NULL
c-MYC	NULL
,	NULL
BCL-2	NULL
,	NULL
or	NULL
BCL-6	NULL
(	NULL
19	NULL
,	NULL
43-46	NULL
)	NULL
.	NULL

AIDS	NULL
IBLP	NULL
,	NULL
non-AIDS	NULL
IBLP	NULL
,	NULL
and	NULL
HYP	NULL
samples	NULL
were	NULL
examined	NULL
histologically	NULL
,	NULL
and	NULL
tissue	NULL
blocks	NULL
were	NULL
trimmed	NULL
to	NULL
exclude	NULL
areas	NULL
of	NULL
necrosis	NULL
or	NULL
surrounding	NULL
non-lymphoid	NULL
tissues	NULL
.	NULL

Microtome	NULL
sections	NULL
(	NULL
5-10	NULL
um	NULL
)	NULL
were	NULL
placed	NULL
directly	NULL
into	NULL
5	NULL
ml	NULL
of	NULL
RNA	NULL
STAT-60	NULL
for	NULL
total	NULL
RNA	NULL
extraction	NULL
(	NULL
Tel-Test	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

cDNA	NULL
was	NULL
synthesized	NULL
from	NULL
0.4	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
Superscript	NULL
II	NULL
,	NULL
GIBCO/BRL	NULL
)	NULL
by	NULL
using	NULL
a	NULL
Smart	NULL
PCR	NULL
cDNA	NULL
Synthesis	NULL
kit	NULL
and	NULL
then	NULL
PCR-amplified	NULL
17-19	NULL
cycles	NULL
by	NULL
using	NULL
conditions	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
CLONTECH	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

SSH	NULL
were	NULL
performed	NULL
between	NULL
AIDS	NULL
IBLP	NULL
1	NULL
versus	NULL
HYP	NULL
1	NULL
or	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
by	NULL
using	NULL
the	NULL
PCR-Select	NULL
cDNA	NULL
Subtraction	NULL
kit	NULL
(	NULL
CLONTECH	NULL
)	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Subtracted	NULL
gene	NULL
fragments	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
TA	NULL
cloning	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
and	NULL
transformed	NULL
into	NULL
DHS	NULL
«	NULL
Escherichia	NULL
coli	NULL
.	NULL

White	NULL
colonies	NULL
containing	NULL
gene	NULL
inserts	NULL
were	NULL
selected	NULL
by	NULL
isopropyl-B-D-thiogalactoside/5-bromo-4-chloro-3-indolyl-B-D-galactoside	NULL
screening	NULL
and	NULL
seeded	NULL
into	NULL
96-well	NULL
microtiter	NULL
plates	NULL
for	NULL
growth	NULL
with	NULL
antibiotic	NULL
selection	NULL
.	NULL

Miniarray	NULL
Filter	NULL
Preparation	NULL
,	NULL
Hybridization	NULL
,	NULL
and	NULL
Analyses	NULL
.	NULL

Samples	NULL
of	NULL
bacterial	NULL
culture	NULL
lysates	NULL
in	NULL
96-well	NULL
plates	NULL
were	NULL
stamped	NULL
with	NULL
a	NULL
replicating	NULL
tool	NULL
(	NULL
V	NULL
&	NULL
P	NULL
Scientific	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
into	NULL
fresh	NULL
96-well	NULL
Thermowell	NULL
plates	NULL
(	NULL
Costar	NULL
)	NULL
for	NULL
PCR	NULL
amplification	NULL
of	NULL
cDNA	NULL
inserts	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
for	NULL
30	NULL
cycles	NULL
(	NULL
94°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
68°C	NULL
for	NULL
3	NULL
min	NULL
)	NULL
,	NULL
and	NULL
the	NULL
average	NULL
size	NULL
of	NULL
insert	NULL
fragments	NULL
was	NULL
~1	NULL
kilobase	NULL
.	NULL

These	NULL
PCR	NULL
products	NULL
were	NULL
identically	NULL
stamped	NULL
onto	NULL
quadruplicate	NULL
NitroPlus	NULL
nitrocellulose	NULL
filters	NULL
(	NULL
Micron	NULL
Separations	NULL
)	NULL
.	NULL

The	NULL
first	NULL
position	NULL
on	NULL
each	NULL
filter	NULL
was	NULL
stamped	NULL
with	NULL
an	NULL
850-bp	NULL
Psfl	NULL
fragment	NULL
of	NULL
the	NULL
plant	NULL
Lemna	NULL
gibba	NULL
RuBPCase	NULL
gene	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
denatured	NULL
and	NULL
neutralized	NULL
for	NULL
5	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
baking	NULL
at	NULL
80°C	NULL
for	NULL
1	NULL
h.	NULL
Random-primed	NULL
,	NULL
radiolabeled	NULL
probes	NULL
were	NULL
made	NULL
by	NULL
using	NULL
a	NULL
Table	NULL
1	NULL
.	NULL

Features	NULL
of	NULL
patient	NULL
samples	NULL
Tissue	NULL
type	NULL
Site	NULL
Lesion	NULL
(	NULL
s	NULL
)	NULL
HYP	NULL
1	NULL
LN	NULL
HIV	NULL
(	NULL
=	NULL
)	NULL
HYP	NULL
2	NULL
LN	NULL
HIV	NULL
(	NULL
+	NULL
)	NULL
AIDS	NULL
IBLP	NULL
1	NULL
LN	NULL
None	NULL
AIDS	NULL
IBLP	NULL
2	NULL
Muscle	NULL
None	NULL
AIDS	NULL
IBLP	NULL
3	NULL
Parotid	NULL
None	NULL
AIDS	NULL
IBLP	NULL
4	NULL
LN	NULL
EBV	NULL
(	NULL
+	NULL
)	NULL
,	NULL
P53	NULL
E6	NULL
,	NULL
LOH	NULL
AIDS	NULL
IBLP	NULL
5	NULL
Bowel	NULL
c-MYC	NULL
,	NULL
p53	NULL
E7	NULL
,	NULL
LOH	NULL
AIDS	NULL
IBLP	NULL
6	NULL
Lung	NULL
EBV	NULL
(	NULL
+	NULL
)	NULL
,	NULL
p53	NULL
E7	NULL
,	NULL
LOH	NULL
AIDS	NULL
IBLP	NULL
7	NULL
LN	NULL
EBV	NULL
(	NULL
+	NULL
)	NULL
,	NULL
p53	NULL
E6	NULL
,	NULL
LOH	NULL
AIDS	NULL
IBLP	NULL
8	NULL
LN	NULL
k-RAS	NULL
,	NULL
p53	NULL
E5,6,7	NULL
,	NULL
LOH	NULL
AIDS	NULL
BL	NULL
Salivary	NULL
Unknown	NULL
Non-AIDS	NULL
IBLP	NULL
1	NULL
LN	NULL
HIV	NULL
(	NULL
=	NULL
)	NULL
Non-AIDS	NULL
IBLP	NULL
2	NULL
Bowel	NULL
HIV	NULL
(	NULL
=	NULL
)	NULL
Hyperplastic	NULL
Tonsil	NULL
Oropharynx	NULL
Tissue	NULL
types	NULL
,	NULL
biopsy	NULL
sites	NULL
,	NULL
and	NULL
characteristic	NULL
genetic	NULL
lesions	NULL
and/or	NULL
viral	NULL
involvement	NULL
in	NULL
patient	NULL
samples	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

AIDS	NULL
IBLP	NULL
samples	NULL
were	NULL
analyzed	NULL
for	NULL
Epstein-Barr	NULL
virus	NULL
,	NULL
human	NULL
herpesvirus-8	NULL
,	NULL
c-MYC	NULL
,	NULL
RAS	NULL
,	NULL
p53	NULL
,	NULL
BCL-2	NULL
,	NULL
and	NULL
BCL-6	NULL
genetic	NULL
alterations	NULL
(	NULL
19	NULL
,	NULL
43-46	NULL
)	NULL
.	NULL

Lymphomas	NULL
with	NULL
p53	NULL
mutations	NULL
in	NULL
exons	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and/or	NULL
7	NULL
terminate	NULL
translation	NULL
early	NULL
or	NULL
contain	NULL
frameshift	NULL
mutations	NULL
.	NULL

These	NULL
five	NULL
tumors	NULL
also	NULL
contain	NULL
loss-of-heterozygosity	NULL
(	NULL
LOH	NULL
)	NULL
alterations	NULL
in	NULL
the	NULL
non-mutated	NULL
alleles	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
Prime-it	NULL
II	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
from	NULL
50	NULL
ng	NULL
of	NULL
unsubtracted	NULL
or	NULL
subtracted	NULL
cDNA	NULL
.	NULL

Probes	NULL
were	NULL
spiked	NULL
with	NULL
0.3	NULL
ng	NULL
of	NULL
the	NULL
850-bp	NULL
RuBPCase	NULL
gene	NULL
fragment	NULL
before	NULL
radiolabeling	NULL
to	NULL
allow	NULL
semi-quantitative	NULL
comparisons	NULL
of	NULL
hybridization	NULL
intensities	NULL
between	NULL
filters	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
at	NULL
42°C	NULL
for	NULL
18	NULL
h	NULL
,	NULL
and	NULL
filters	NULL
were	NULL
washed	NULL
with	NULL
0.1	NULL
%	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
for	NULL
45	NULL
min	NULL
at	NULL
52°C	NULL
.	NULL

Hybridization	NULL
signals	NULL
were	NULL
determined	NULL
visually	NULL
by	NULL
auto-radiography	NULL
and	NULL
quantitatively	NULL
with	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Mo-lecular	NULL
Dynamics	NULL
)	NULL
by	NULL
using	NULL
the	NULL
program	NULL
IMAGEQUANT	NULL
.	NULL

``	NULL
Virtual	NULL
``	NULL
Northern	NULL
Analyses	NULL
of	NULL
Tissues	NULL
.	NULL

PCR-amplified	NULL
cDNA	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
,	NULL
obtained	NULL
from	NULL
equivalent	NULL
amounts	NULL
of	NULL
reverse-transcribed	NULL
total	NULL
RNA	NULL
,	NULL
was	NULL
fractionated	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
alkaline-transferred	NULL
for	NULL
1	NULL
hr	NULL
to	NULL
a	NULL
MagnaCharge	NULL
nylon	NULL
membrane	NULL
by	NULL
using	NULL
a	NULL
TurboBlotter	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
random-primed	NULL
,	NULL
radiolabeled	NULL
TCL1	NULL
or	NULL
BCA-1	NULL
cDNA	NULL
fragment	NULL
probes	NULL
.	NULL

Equal	NULL
lane	NULL
loading	NULL
was	NULL
determined	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Immunohistochemical	NULL
Staining	NULL
of	NULL
TCL1	NULL
and	NULL
Fascin	NULL
in	NULL
Tissues	NULL
.	NULL

Rabbit	NULL
antisera	NULL
were	NULL
generated	NULL
against	NULL
a	NULL
purified	NULL
glutathione	NULL
S-transferase-TCL1	NULL
fusion	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Formalin-fixed	NULL
tissues	NULL
on	NULL
glass	NULL
slides	NULL
were	NULL
incubated	NULL
with	NULL
blocking	NULL
buffer	NULL
and	NULL
subsequently	NULL
with	NULL
TCL1	NULL
antisera	NULL
.	NULL

Slides	NULL
were	NULL
rinsed	NULL
,	NULL
and	NULL
biotinylated	NULL
goat	NULL
anti-rabbit	NULL
Ig	NULL
(	NULL
DAKO	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Slides	NULL
were	NULL
washed	NULL
,	NULL
and	NULL
streptavidin	NULL
was	NULL
added	NULL
,	NULL
followed	NULL
by	NULL
diaminobenzidine	NULL
HCl	NULL
incubation	NULL
and	NULL
counterstaining	NULL
in	NULL
Mayer	NULL
's	NULL
hematoxylin	NULL
(	NULL
DAKO	NULL
)	NULL
.	NULL

Formalin-fixed	NULL
tissue	NULL
sections	NULL
were	NULL
also	NULL
stained	NULL
with	NULL
a	NULL
fascin	NULL
mAb	NULL
to	NULL
detect	NULL
dendritic	NULL
reticulum	NULL
cells	NULL
(	NULL
DRC	NULL
)	NULL
as	NULL
described	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
TCL1	NULL
and	NULL
BCA-1	NULL
in	NULL
Fresh-Frozen	NULL
Patient	NULL
Samples	NULL
.	NULL

Two	NULL
independent	NULL
bidirectional	NULL
SSH	NULL
were	NULL
performed	NULL
to	NULL
identify	NULL
AIDS	NULL
lymphoma-expressed	NULL
genes	NULL
.	NULL

In	NULL
the	NULL
first	NULL
subtraction	NULL
,	NULL
AIDS	NULL
IBLP	NULL
1	NULL
cDNA	NULL
was	NULL
paired	NULL
with	NULL
HYP	NULL
1	NULL
cDNA	NULL
and	NULL
in	NULL
the	NULL
second	NULL
,	NULL
this	NULL
AIDS	NULL
IBLP	NULL
sample	NULL
was	NULL
paired	NULL
with	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
cDNA	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
first	NULL
subtraction	NULL
reduced	NULL
genes	NULL
that	NULL
were	NULL
transiently	NULL
up-	NULL
or	NULL
down-regulated	NULL
because	NULL
of	NULL
immune	NULL
system	NULL
activation	NULL
as	NULL
often	NULL
occurs	NULL
in	NULL
premalignant	NULL
persistent	NULL
generalized	NULL
lymphadenopathy	NULL
in	NULL
early	NULL
HIV	NULL
infection	NULL
(	NULL
4	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
second	NULL
subtraction	NULL
removed	NULL
cDNAs	NULL
expressed	NULL
in	NULL
common	NULL
between	NULL
two	NULL
lymphomas	NULL
of	NULL
the	NULL
same	NULL
histologic	NULL
type	NULL
and	NULL
enriched	NULL
for	NULL
up-	NULL
or	NULL
down-regulated	NULL
sequences	NULL
in	NULL
severely	NULL
immunosuppressed	NULL
individuals	NULL
.	NULL

Over	NULL
2,000	NULL
cloned	NULL
cDNA	NULL
fragments	NULL
from	NULL
these	NULL
subtractions	NULL
were	NULL
arrayed	NULL
on	NULL
nitrocellulose	NULL
filters	NULL
and	NULL
independently	NULL
hybridized	NULL
with	NULL
tester	NULL
,	NULL
driver	NULL
,	NULL
and	NULL
subtracted	NULL
cDNA	NULL
probes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Approximately	NULL
120	NULL
of	NULL
the	NULL
clones	NULL
that	NULL
differentially	NULL
hybridized	NULL
were	NULL
sequenced	NULL
.	NULL

TCLI	NULL
,	NULL
an	NULL
oncogene	NULL
implicated	NULL
in	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
development	NULL
,	NULL
and	NULL
BCA-1	NULL
,	NULL
a	NULL
recently	NULL
identified	NULL
B	NULL
cell	NULL
CXC-family	NULL
chemoattractant	NULL
,	NULL
were	NULL
identified	NULL
in	NULL
these	NULL
characterized	NULL
isolates	NULL
and	NULL
were	NULL
differentially	NULL
expressed	NULL
in	NULL
opposite	NULL
directions	NULL
(	NULL
40	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

TCL1I	NULL
was	NULL
identified	NULL
in	NULL
the	NULL
AIDS	NULL
IBLP	NULL
1	NULL
minus	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
subtraction	NULL
,	NULL
whereas	NULL
BCA-1	NULL
was	NULL
found	NULL
in	NULL
both	NULL
HYP	NULL
1	NULL
and	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
minus	NULL
AIDS	NULL
IBLP	NULL
1	NULL
subtractions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Differential	NULL
Expression	NULL
Profiles	NULL
of	NULL
TCL1	NULL
and	NULL
BCA-1	NULL
.	NULL

Northern	NULL
blots	NULL
to	NULL
confirm	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
TCLLI	NULL
and	NULL
BCA-1	NULL
were	NULL
not	NULL
possible	NULL
because	NULL
of	NULL
the	NULL
exceptionally	NULL
small	NULL
sizes	NULL
of	NULL
the	NULL
tissue	NULL
samples	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Therefore	NULL
,	NULL
virtual	NULL
Northern	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
PCR-amplified	NULL
cDNA	NULL
from	NULL
tissue	NULL
samples	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

TCL1I	NULL
was	NULL
abundantly	NULL
expressed	NULL
in	NULL
AIDS	NULL
IBLP	NULL
samples	NULL
1	NULL
and	NULL
2	NULL
(	NULL
which	NULL
both	NULL
lack	NULL
known	NULL
genetic	NULL
lesions	NULL
or	NULL
viral	NULL
involvement	NULL
)	NULL
but	NULL
was	NULL
absent	NULL
in	NULL
non-AIDS	NULL
IBLP	NULL
samples	NULL
1	NULL
and	NULL
2	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
TCLI	NULL
were	NULL
detected	NULL
in	NULL
HYP	NULL
samples	NULL
from	NULL
HIV-infected	NULL
and	NULL
uninfected	NULL
individuals	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
TCL1	NULL
,	NULL
BCA-1	NULL
was	NULL
highly	NULL
expressed	NULL
in	NULL
HYP	NULL
samples	NULL
1	NULL
and	NULL
2	NULL
as	NULL
well	NULL
as	NULL
in	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
but	NULL
was	NULL
absent	NULL
in	NULL
non-lymph	NULL
node-derived	NULL
tumors	NULL
as	NULL
well	NULL
as	NULL
lymph	NULL
node-derived	NULL
Medical	NULL
Sciences	NULL
:	NULL
Teitell	NULL
et	NULL
al	NULL
.	NULL

Tissue	NULL
Type	NULL
Non-AIDS	NULL
IBLP	NULL
#	NULL
1	NULL
Non-AIDS	NULL
IBLP	NULL
#	NULL
2	NULL
HIV	NULL
(	NULL
-	NULL
)	NULL
HYP	NULL
#	NULL
1	NULL
AIDS	NULL
IBLP	NULL
#	NULL
2	NULL
HIV	NULL
(	NULL
+	NULL
)	NULL
HYP	NULL
#	NULL
2	NULL
.	NULL

AIDS	NULL
IBLP	NULL
#	NULL
1	NULL
TCL1	NULL
BCA-1	NULL
Location	NULL
Lymph	NULL
Node	NULL
Lymph	NULL
Node	NULL
G.1	NULL
.	NULL

Tract	NULL
Skeletal	NULL
Muscle	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Virtual	NULL
Northern	NULL
analysis	NULL
of	NULL
TCLI	NULL
and	NULL
BCA-1	NULL
gene	NULL
expression	NULL
in	NULL
tissue	NULL
samples	NULL
.	NULL

(	NULL
Upper	NULL
)	NULL
Hybridization	NULL
with	NULL
a	NULL
350-bp	NULL
random-primed	NULL
TCL	NULL
]	NULL
cDNA	NULL
fragment	NULL
.	NULL

AIDS	NULL
IBLP	NULL
samples	NULL
from	NULL
lymph	NULL
node	NULL
or	NULL
muscle	NULL
expressed	NULL
abundant	NULL
TCLI	NULL
,	NULL
whereas	NULL
low	NULL
levels	NULL
were	NULL
expressed	NULL
in	NULL
both	NULL
HYP	NULL
samples	NULL
.	NULL

(	NULL
Lower	NULL
)	NULL
The	NULL
filter	NULL
from	NULL
Upper	NULL
was	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
200-bp	NULL
random-primed	NULL
BCA-I	NULL
cDNA	NULL
fragment	NULL
.	NULL

BCA-1	NULL
was	NULL
expressed	NULL
in	NULL
both	NULL
HYP	NULL
and	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
derived	NULL
from	NULL
a	NULL
lymph	NULL
node	NULL
but	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
either	NULL
AIDS	NULL
IBLP	NULL
1	NULL
or	NULL
2	NULL
or	NULL
in	NULL
non-AIDS	NULL
IBLP	NULL
2	NULL
derived	NULL
from	NULL
the	NULL
gastrointestinal	NULL
tract	NULL
.	NULL

Ethidium	NULL
bromide	NULL
gel	NULL
staining	NULL
demonstrated	NULL
equal	NULL
lane	NULL
loading	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

AIDS	NULL
IBLP	NULL
1	NULL
.	NULL

BCA-1	NULL
is	NULL
expressed	NULL
in	NULL
secondary	NULL
human	NULL
lymphoid	NULL
tissues	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Mice	NULL
also	NULL
express	NULL
a	NULL
BCA-1	NULL
homologue	NULL
,	NULL
B	NULL
:	NULL
AIDS	NULL
IBLP	NULL
#	NULL
1	NULL
D	NULL
:	NULL
non-AIDS	NULL
IBLP	NULL
#	NULL
1	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
9811	NULL
termed	NULL
BLC	NULL
,	NULL
and	NULL
antisense	NULL
in	NULL
situ	NULL
hybridization	NULL
has	NULL
demonstrated	NULL
a	NULL
reticular	NULL
staining	NULL
pattern	NULL
for	NULL
BLC	NULL
in	NULL
lymphoid	NULL
follicles	NULL
(	NULL
51	NULL
)	NULL
.	NULL

This	NULL
staining	NULL
pattern	NULL
suggested	NULL
that	NULL
mouse	NULL
DRC	NULL
may	NULL
secrete	NULL
BLC	NULL
and	NULL
,	NULL
by	NULL
analogy	NULL
,	NULL
that	NULL
human	NULL
DRC	NULL
also	NULL
secrete	NULL
BCA-1	NULL
,	NULL
although	NULL
neither	NULL
association	NULL
has	NULL
been	NULL
proven	NULL
.	NULL

TCL1	NULL
Protein	NULL
Is	NULL
Expressed	NULL
in	NULL
Distinct	NULL
Locations	NULL
in	NULL
AIDS	NULL
IBLP	NULL
,	NULL
HYP	NULL
,	NULL
and	NULL
Tonsil	NULL
.	NULL

Tissue-localization	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
definitively	NULL
identify	NULL
the	NULL
cell	NULL
types	NULL
expressing	NULL
TCLI	NULL
and	NULL
BCA-1	NULL
in	NULL
AIDS	NULL
IBLP	NULL
and	NULL
non-AIDS	NULL
IBLP	NULL
tumor	NULL
samples	NULL
.	NULL

TCL1	NULL
rabbit	NULL
antisera	NULL
staining	NULL
of	NULL
formalin-fixed	NULL
lymphoma	NULL
tissues	NULL
demonstrated	NULL
intense	NULL
,	NULL
widespread	NULL
expression	NULL
of	NULL
TCL1	NULL
protein	NULL
restricted	NULL
to	NULL
tumor	NULL
cells	NULL
in	NULL
AIDS	NULL
IBLP	NULL
samples	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
4	NULL
and	NULL
B	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TCL1	NULL
protein	NULL
staining	NULL
was	NULL
mainly	NULL
cytoplasmic	NULL
,	NULL
although	NULL
some	NULL
nuclear	NULL
staining	NULL
was	NULL
also	NULL
seen	NULL
.	NULL

TCL1	NULL
protein	NULL
was	NULL
not	NULL
detected	NULL
within	NULL
heterogeneous	NULL
nonlymphoma	NULL
cell	NULL
elements	NULL
of	NULL
these	NULL
same	NULL
tissue	NULL
sections	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
TCL1	NULL
protein	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
non-AIDS	NULL
IBLP	NULL
samples	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
and	NULL
D	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
SSH	NULL
isolation	NULL
results	NULL
and	NULL
virtual	NULL
Northern	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
TCL1	NULL
protein	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
distinctive	NULL
locations	NULL
in	NULL
HYP	NULL
from	NULL
HIV-infected	NULL
and	NULL
uninfected	NULL
individuals	NULL
.	NULL

Staining	NULL
was	NULL
intense	NULL
and	NULL
widespread	NULL
within	NULL
mantle	NULL
zone	NULL
B	NULL
cells	NULL
.	NULL

Intense	NULL
TCL1	NULL
staining	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
rare	NULL
interfollicular	NULL
zone	NULL
cells	NULL
,	NULL
none	NULL
of	NULL
which	NULL
morphologically	NULL
resembled	NULL
transformed	NULL
lymphoid	NULL
cells	NULL
or	NULL
immunoblasts	NULL
(	NULL
Fig	NULL
.	NULL

2£	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Lower	NULL
levels	NULL
of	NULL
TCL1	NULL
staining	NULL
was	NULL
seen	NULL
in	NULL
follicle	NULL
center	NULL
cells	NULL
,	NULL
including	NULL
both	NULL
centroblasts	NULL
and	NULL
centro-cytes	NULL
.	NULL

Hyperplastic	NULL
tonsil	NULL
showed	NULL
a	NULL
pattern	NULL
of	NULL
intense	NULL
TCL1	NULL
staining	NULL
in	NULL
germinal	NULL
centers	NULL
preferentially	NULL
located	NULL
in	NULL
mantle-zone	NULL
B	NULL
cells	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
HYP	NULL
(	NULL
Fig	NULL
.	NULL

2F	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
cells	NULL
are	NULL
not	NULL
distinguishable	NULL
by	NULL
routine	NULL
histologic	NULL
examination	NULL
with	NULL
light	NULL
microscopy	NULL
,	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
tissue	NULL
contained	NULL
residual	NULL
fascin	NULL
antibody-stained	NULL
DRC	NULL
that	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
AIDS	NULL
IBLP	NULL
1	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

AIDS	NULL
IBLP	NULL
1	NULL
may	NULL
lack	NULL
DRC	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
may	NULL
contain	NULL
DRC	NULL
that	NULL
E	NULL
:	NULL
HYP	NULL
#	NULL
1	NULL
F	NULL
:	NULL
Tonsil	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

TCL1	NULL
antisera	NULL
staining	NULL
of	NULL
formalin-fixed	NULL
tissues	NULL
.	NULL

An	NULL
intense	NULL
positive	NULL
signal	NULL
was	NULL
confined	NULL
to	NULL
the	NULL
large	NULL
immunoblastic/plasmacytic	NULL
tumor	NULL
cells	NULL
in	NULL
AIDS	NULL
IBLP	NULL
1	NULL
(	NULL
4	NULL
,	NULL
X400X	NULL
%	NULL
;	NULL
B	NULL
,	NULL
X	NULL
1,000	NULL
magnification	NULL
)	NULL
,	NULL
whereas	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
(	NULL
C	NULL
,	NULL
X400	NULL
;	NULL
D	NULL
,	NULL
X1,000	NULL
magnification	NULL
)	NULL
was	NULL
negative	NULL
.	NULL

Non-tumor	NULL
cell	NULL
elements	NULL
were	NULL
negative	NULL
for	NULL
TCL1	NULL
protein	NULL
expression	NULL
in	NULL
both	NULL
samples	NULL
.	NULL

TCL1	NULL
staining	NULL
appeared	NULL
mainly	NULL
within	NULL
the	NULL
cytoplasm	NULL
.	NULL

Germinal	NULL
center	NULL
B	NULL
cells	NULL
also	NULL
stained	NULL
with	NULL
TCL1	NULL
antisera	NULL
(	NULL
E	NULL
,	NULL
X100	NULL
;	NULL
F	NULL
,	NULL
X200	NULL
magnification	NULL
)	NULL
.	NULL

Both	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
HYP	NULL
contained	NULL
activated	NULL
germinal	NULL
centers	NULL
that	NULL
reacted	NULL
with	NULL
TCL1	NULL
antisera	NULL
.	NULL

In	NULL
these	NULL
samples	NULL
,	NULL
TCL1	NULL
staining	NULL
was	NULL
most	NULL
intense	NULL
in	NULL
naive	NULL
,	NULL
nonproliferating	NULL
mantle-zone	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
rare	NULL
interfollicular	NULL
zone	NULL
cells	NULL
of	NULL
unknown	NULL
phenotype	NULL
.	NULL

A	NULL
reduced	NULL
staining	NULL
intensity	NULL
was	NULL
seen	NULL
in	NULL
follicle-center	NULL
cells	NULL
(	NULL
centroblasts	NULL
and	NULL
centrocytes	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
level	NULL
of	NULL
staining	NULL
in	NULL
the	NULL
different	NULL
tissues	NULL
analyzed	NULL
correlated	NULL
with	NULL
the	NULL
TCLI	NULL
transcript	NULL
levels	NULL
detected	NULL
by	NULL
virtual	NULL
Northern	NULL
analysis	NULL
.	NULL

9812	NULL
Medical	NULL
Sciences	NULL
:	NULL
Teitell	NULL
et	NULL
al	NULL
.	NULL

~	NULL
an	NULL
a~	NULL
a	NULL
G	NULL
£	NULL
£	NULL
9	NULL
5	NULL
3	NULL
&	NULL
3	NULL
3	NULL
<	NULL
4	NULL
g	NULL
m	NULL
=	NULL
m	NULL
m	NULL
C	NULL
Genetic/	NULL
0	NULL
@	NULL
@	NULL
i	NULL
m.	NULL
u-	NULL
m.	NULL
Lu	NULL
.	NULL

x	NULL
“	NULL
|	NULL
2	NULL
C	NULL
g	NULL
o	NULL
ca	NULL
oa	NULL
#	NULL
a	NULL
viral	NULL
6	NULL
06	NULL
o	NULL
C	NULL
im	NULL
in	NULL
wm	NULL
w	NULL
in	NULL
Lesions	NULL
2	NULL
6	NULL
e	NULL
2	NULL
@	NULL
a	NULL
QA	NULL
A	NULL
a	NULL
MWK	NULL
-	NULL
-	NULL
#	NULL
lle	NULL
TCL1	NULL
Sample	NULL
_	NULL
©	NULL
%	NULL
2	NULL
g	NULL
%	NULL
2	NULL
$	NULL
&	NULL
2	NULL
Number	NULL
A	NULL
Q	NULL
A	NULL
y	NULL
A	NULL
.	NULL

A	NULL
.	NULL

A.	NULL
o.	NULL
n.	NULL
_	NULL
uaf	NULL
o	NULL
_d	NULL
_	NULL
_I	NULL
~d	NULL
-J	NULL
208	NULL
98	NULL
3	NULL
;	NULL
P	NULL
P	NULL
9	NULL
P	NULL
9	NULL
w	NULL
a	NULL
a	NULL
w	NULL
a	NULL
-	NULL
a	NULL
a	NULL
8	NULL
&	NULL
8	NULL
a	NULL
8	NULL
8	NULL
8	NULL
8	NULL
4°	NULL
<	NULL
<	NULL
4	NULL
40	NULL
4	NULL
4	NULL
4	NULL
<	NULL
4	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Virtual	NULL
Northern	NULL
analysis	NULL
of	NULL
TCLI	NULL
gene	NULL
expression	NULL
in	NULL
AIDS	NULL
IBLP	NULL
and	NULL
AIDS-related	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
samples	NULL
.	NULL

Blots	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
350-bp	NULL
random-primed	NULL
TCL	NULL
I	NULL
cDNA	NULL
fragment	NULL
.	NULL

All	NULL
of	NULL
the	NULL
IBLP	NULL
samples	NULL
tested	NULL
were	NULL
originally	NULL
classified	NULL
as	NULL
B	NULL
cell	NULL
immunoblastic	NULL
lymphomas	NULL
by	NULL
Working	NULL
Formulation	NULL
criteria	NULL
,	NULL
and	NULL
as	NULL
AIDS	NULL
IBLP	NULL
by	NULL
the	NULL
Revised	NULL
European-American	NULL
Lymphoma	NULL
(	NULL
REAL	NULL
)	NULL
AIDS-related	NULL
classification	NULL
,	NULL
except	NULL
lane	NULL
4	NULL
,	NULL
which	NULL
is	NULL
an	NULL
AIDS-related	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

AIDS	NULL
IBLP	NULL
and	NULL
an	NULL
AIDS-related	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
with	NULL
and	NULL
without	NULL
known	NULL
genetic	NULL
or	NULL
viral	NULL
lesions	NULL
express	NULL
TCL1	NULL
.	NULL

Ethidium	NULL
bromide	NULL
gel	NULL
staining	NULL
demonstrated	NULL
equal	NULL
lane	NULL
load-ing	NULL
,	NULL
and	NULL
detection	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
in	NULL
each	NULL
lane	NULL
showed	NULL
that	NULL
the	NULL
original	NULL
RNA	NULL
templates	NULL
of	NULL
each	NULL
tissue	NULL
sample	NULL
were	NULL
of	NULL
similar	NULL
quality	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

do	NULL
not	NULL
express	NULL
fascin	NULL
or	NULL
BCA-1	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
spectrum	NULL
of	NULL
genes	NULL
isolated	NULL
by	NULL
SSH	NULL
and	NULL
with	NULL
virtual	NULL
Northern	NULL
results	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
BCA-1	NULL
in	NULL
non-AIDS	NULL
IBLP	NULL
1	NULL
,	NULL
coupled	NULL
with	NULL
residual	NULL
fascin-positive	NULL
antibody	NULL
staining	NULL
in	NULL
this	NULL
tumor	NULL
,	NULL
compared	NULL
with	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
both	NULL
BCA-1	NULL
and	NULL
fascin-stained	NULL
cells	NULL
in	NULL
AIDS	NULL
IBLP	NULL
1	NULL
,	NULL
also	NULL
suggest	NULL
that	NULL
DRC	NULL
express	NULL
BCA-1	NULL
.	NULL

The	NULL
concordance	NULL
of	NULL
BCA-1	NULL
expression	NULL
and	NULL
fascin	NULL
antibody	NULL
staining	NULL
in	NULL
these	NULL
two	NULL
tumor	NULL
samples	NULL
,	NULL
along	NULL
with	NULL
concordant	NULL
expression	NULL
in	NULL
HYP	NULL
1	NULL
and	NULL
2	NULL
,	NULL
also	NULL
further	NULL
confirms	NULL
that	NULL
both	NULL
subtractions	NULL
efficiently	NULL
isolated	NULL
differentially	NULL
expressed	NULL
genes	NULL
.	NULL

TCL1	NULL
Expression	NULL
in	NULL
AIDS	NULL
NHL	NULL
with	NULL
or	NULL
Without	NULL
Genetic/	NULL
Viral	NULL
Alterations	NULL
.	NULL

AIDS	NULL
IBLP	NULL
samples	NULL
1	NULL
and	NULL
2	NULL
expressed	NULL
abundant	NULL
TCL1	NULL
protein	NULL
in	NULL
lymphoma	NULL
cells	NULL
without	NULL
additional	NULL
genetic	NULL
alterations	NULL
or	NULL
viral	NULL
involvement	NULL
.	NULL

This	NULL
observation	NULL
,	NULL
coupled	NULL
with	NULL
detection	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
TCL1	NULL
protein	NULL
in	NULL
nonproliferating	NULL
mantle-zone	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
scattered	NULL
,	NULL
rare	NULL
interfollicular-zone	NULL
cells	NULL
of	NULL
HYP	NULL
and	NULL
tonsil	NULL
,	NULL
suggests	NULL
that	NULL
TCL1	NULL
expression	NULL
occurs	NULL
early	NULL
in	NULL
AIDS	NULL
lymphomagenesis	NULL
.	NULL

We	NULL
therefore	NULL
considered	NULL
whether	NULL
AIDS	NULL
NHL	NULL
tumors	NULL
with	NULL
identified	NULL
oncogenic	NULL
alterations	NULL
,	NULL
(	NULL
perhaps	NULL
representing	NULL
later	NULL
stage	NULL
lymphomas	NULL
)	NULL
also	NULL
expressed	NULL
TCL1I	NULL
.	NULL

Virtual	NULL
Northern	NULL
analyses	NULL
demonstrated	NULL
that	NULL
the	NULL
large	NULL
majority	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
six	NULL
of	NULL
eight	NULL
)	NULL
AIDS	NULL
IBLP	NULL
patient	NULL
samples	NULL
tested	NULL
expressed	NULL
TCL1	NULL
,	NULL
including	NULL
three	NULL
of	NULL
five	NULL
lymphoma	NULL
samples	NULL
of	NULL
this	NULL
class	NULL
with	NULL
additional	NULL
identified	NULL
genetic	NULL
aberrations	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
TCL1	NULL
is	NULL
more	NULL
consistently	NULL
expressed	NULL
in	NULL
AIDS	NULL
IBLP	NULL
than	NULL
any	NULL
other	NULL
known	NULL
oncogene	NULL
previously	NULL
analyzed	NULL
.	NULL

This	NULL
prevalent	NULL
expression	NULL
strongly	NULL
supports	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
TCL1I	NULL
in	NULL
the	NULL
development	NULL
of	NULL
this	NULL
class	NULL
of	NULL
AIDS	NULL
NHL	NULL
.	NULL

Interestingly	NULL
,	NULL
an	NULL
AIDS-related	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
derived	NULL
from	NULL
a	NULL
salivary	NULL
gland	NULL
tumor	NULL
also	NULL
expressed	NULL
moderate	NULL
mRNA	NULL
.	NULL

This	NULL
latter	NULL
observation	NULL
suggests	NULL
that	NULL
additional	NULL
classes	NULL
of	NULL
AIDS	NULL
NHL	NULL
should	NULL
also	NULL
be	NULL
examined	NULL
for	NULL
TCLI	NULL
expression	NULL
.	NULL

DISCUSSION	NULL
Two	NULL
independent	NULL
rounds	NULL
of	NULL
SSH	NULL
were	NULL
performed	NULL
to	NULL
isolate	NULL
genes	NULL
that	NULL
are	NULL
differentially	NULL
expressed	NULL
in	NULL
AIDS	NULL
IBLP	NULL
versus	NULL
non-AIDS	NULL
IBLP	NULL
tumors	NULL
or	NULL
activated	NULL
lymph	NULL
node	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
differential	NULL
expression	NULL
of	NULL
SSH	NULL
isolated	NULL
genes	NULL
was	NULL
then	NULL
confirmed	NULL
by	NULL
virtual	NULL
Northern	NULL
blots	NULL
and	NULL
assigned	NULL
to	NULL
specific	NULL
cell	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
populations	NULL
by	NULL
immunohistochemical	NULL
staining	NULL
(	NULL
and	NULL
antisense	NULL
in	NULL
situ	NULL
hybridizations	NULL
;	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
of	NULL
tumor	NULL
and	NULL
normal	NULL
tissue	NULL
samples	NULL
.	NULL

These	NULL
combined	NULL
steps	NULL
define	NULL
a	NULL
powerful	NULL
strategy	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
differentially	NULL
expressed	NULL
genes	NULL
from	NULL
specific	NULL
cells	NULL
in	NULL
heterogeneous	NULL
surgical	NULL
or	NULL
biopsy	NULL
tissue	NULL
samples	NULL
.	NULL

Among	NULL
the	NULL
differentially	NULL
expressed	NULL
genes	NULL
identified	NULL
with	NULL
this	NULL
approach	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
TCL1	NULL
because	NULL
of	NULL
its	NULL
compelling	NULL
biology	NULL
in	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
its	NULL
reported	NULL
oncogenic	NULL
activity	NULL
in	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
.	NULL

TCLLI	NULL
encodes	NULL
a	NULL
predominantly	NULL
cytoplasmic	NULL
protein	NULL
of	NULL
unresolved	NULL
function	NULL
that	NULL
belongs	NULL
to	NULL
a	NULL
novel	NULL
family	NULL
of	NULL
recently	NULL
identified	NULL
oncogenes	NULL
that	NULL
now	NULL
includes	NULL
the	NULL
MTCPI	NULL
and	NULL
TCLIb	NULL
genes	NULL
(	NULL
42	NULL
,	NULL
52-55	NULL
)	NULL
.	NULL

Although	NULL
its	NULL
expression	NULL
was	NULL
originally	NULL
reported	NULL
to	NULL
be	NULL
limited	NULL
to	NULL
developing	NULL
lymphocytes	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
fetal	NULL
thymocytes	NULL
,	NULL
pre-B	NULL
cells	NULL
,	NULL
and	NULL
immature	NULL
surface	NULL
Ig	NULL
M-expressing	NULL
B	NULL
cells	NULL
in	NULL
bone	NULL
marrow	NULL
)	NULL
and	NULL
to	NULL
endemic	NULL
(	NULL
primarily	NULL
Epstein-Barr	NULL
virus*	NULL
)	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
tumor	NULL
cell	NULL
lines	NULL
,	NULL
TCL	NULL
expression	NULL
recently	NULL
has	NULL
been	NULL
documented	NULL
in	NULL
many	NULL
immortalized	NULL
B	NULL
lymphoblastoid	NULL
and	NULL
B	NULL
cell	NULL
tumor	NULL
lines	NULL
(	NULL
40-42	NULL
)	NULL
.	NULL

TCLI	NULL
transcripts	NULL
have	NULL
also	NULL
been	NULL
reported	NULL
in	NULL
CD19*	NULL
sorted	NULL
peripheral-blood	NULL
lymphocytes	NULL
and	NULL
in	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
,	NULL
although	NULL
the	NULL
cell	NULL
(	NULL
s	NULL
)	NULL
of	NULL
origin	NULL
was	NULL
not	NULL
defined	NULL
in	NULL
these	NULL
latter	NULL
tissues	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Using	NULL
immunohistochemical	NULL
staining	NULL
,	NULL
we	NULL
show	NULL
that	NULL
HYP	NULL
and	NULL
tonsil	NULL
express	NULL
TCL1	NULL
protein	NULL
,	NULL
with	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
mantle-zone	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
rare	NULL
interfollicular-zone	NULL
cells	NULL
(	NULL
none	NULL
of	NULL
which	NULL
resembled	NULL
immunoblasts	NULL
)	NULL
.	NULL

The	NULL
mantle	NULL
zone	NULL
contains	NULL
naive	NULL
,	NULL
unactivated	NULL
B	NULL
cells	NULL
that	NULL
may	NULL
become	NULL
activated	NULL
within	NULL
follicles	NULL
and	NULL
differentiate	NULL
into	NULL
either	NULL
mature	NULL
memory	NULL
B	NULL
cells	NULL
or	NULL
Ig-secreting	NULL
plasma	NULL
cells	NULL
(	NULL
ref	NULL
.	NULL

56	NULL
,	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

57-59	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
widespread	NULL
TCL1	NULL
expression	NULL
in	NULL
quiescent	NULL
mantle-zone	NULL
B	NULL
cells	NULL
suggests	NULL
that	NULL
TCL1I	NULL
expression	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
B	NULL
cell	NULL
survival	NULL
rather	NULL
than	NULL
in	NULL
proliferation	NULL
or	NULL
Ig/T	NULL
cell	NULL
receptor	NULL
gene	NULL
rearrangements	NULL
as	NULL
previously	NULL
speculated	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Mantle-zone	NULL
B	NULL
cells	NULL
express	NULL
abundant	NULL
BCL-2	NULL
protein	NULL
that	NULL
serves	NULL
to	NULL
protect	NULL
these	NULL
resting	NULL
B	NULL
cells	NULL
from	NULL
apoptosis	NULL
(	NULL
58	NULL
,	NULL
60-62	NULL
)	NULL
.	NULL

Elevated	NULL
TCLI	NULL
expression	NULL
within	NULL
this	NULL
same	NULL
quiescent	NULL
B	NULL
cell	NULL
population	NULL
also	NULL
may	NULL
reflect	NULL
a	NULL
role	NULL
in	NULL
conferring	NULL
resistance	NULL
to	NULL
apoptosis	NULL
,	NULL
although	NULL
this	NULL
possibility	NULL
remains	NULL
to	NULL
be	NULL
tested	NULL
.	NULL

Fi-nally	NULL
,	NULL
the	NULL
mantle	NULL
zone	NULL
is	NULL
physically	NULL
juxtaposed	NULL
to	NULL
the	NULL
follicle	NULL
center	NULL
,	NULL
which	NULL
contains	NULL
areas	NULL
of	NULL
extensive	NULL
apoptotic	NULL
activity	NULL
(	NULL
along	NULL
with	NULL
reduced	NULL
BCL-2	NULL
expression	NULL
)	NULL
in	NULL
which	NULL
we	NULL
also	NULL
find	NULL
decreased	NULL
levels	NULL
of	NULL
TCL1	NULL
protein	NULL
expression	NULL
.	NULL

This	NULL
concurrence	NULL
lends	NULL
further	NULL
support	NULL
for	NULL
an	NULL
antiapoptotic	NULL
role	NULL
for	NULL
TCL1I	NULL
.	NULL

Aberrant	NULL
TCL1I	NULL
expression	NULL
has	NULL
been	NULL
previously	NULL
reported	NULL
in	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
with	NULL
chromosomal	NULL
rearrangements	NULL
that	NULL
juxtapose	NULL
the	NULL
TCL	NULL
I	NULL
gene	NULL
in	NULL
proximity	NULL
to	NULL
the	NULL
T	NULL
cell-specific	NULL
enhancers	NULL
of	NULL
either	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
«	NULL
/8	NULL
or	NULL
B	NULL
loci	NULL
(	NULL
35-39	NULL
)	NULL
.	NULL

Transgenic	NULL
mice	NULL
expressing	NULL
either	NULL
or	NULL
MTCPI	NULL
from	NULL
promoters	NULL
that	NULL
restrict	NULL
expression	NULL
to	NULL
T	NULL
cells	NULL
developed	NULL
early	NULL
T	NULL
cell	NULL
proliferative	NULL
expansions	NULL
that	NULL
progressed	NULL
to	NULL
T	NULL
cell	NULL
leukemia	NULL
by	NULL
15	NULL
months	NULL
of	NULL
age	NULL
(	NULL
63	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
BCL-2	NULL
transgenic	NULL
mice	NULL
also	NULL
developed	NULL
B	NULL
cell	NULL
lymphomas	NULL
slowly	NULL
and	NULL
in	NULL
moderate	NULL
numbers	NULL
,	NULL
in	NULL
a	NULL
manner	NULL
paralleling	NULL
the	NULL
time	NULL
course	NULL
and	NULL
occurrence	NULL
of	NULL
T	NULL
cell	NULL
tumors	NULL
in	NULL
TCLI	NULL
transgenic	NULL
mice	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

65	NULL
and	NULL
66	NULL
)	NULL
.	NULL

Humans	NULL
may	NULL
also	NULL
sustain	NULL
preleukemic	NULL
TCL	NULL
]	NULL
I	NULL
translocations	NULL
for	NULL
many	NULL
years	NULL
before	NULL
overt	NULL
leukemia/	NULL
lymphoma	NULL
formation	NULL
(	NULL
67	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
observations	NULL
provide	NULL
strong	NULL
support	NULL
for	NULL
the	NULL
oncogenic	NULL
potential	NULL
of	NULL
TCLLI	NULL
and	NULL
suggest	NULL
that	NULL
TCL	NULL
1	NULL
may	NULL
function	NULL
to	NULL
promote	NULL
cell	NULL
survival	NULL
rather	NULL
than	NULL
affecting	NULL
cell	NULL
proliferation	NULL
.	NULL

AIDS	NULL
IBLP	NULL
are	NULL
derived	NULL
from	NULL
postgerminal	NULL
center	NULL
cells	NULL
and	NULL
not	NULL
from	NULL
resting	NULL
mantle-zone	NULL
B	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Elevated	NULL
TCL1I	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
may	NULL
result	NULL
from	NULL
an	NULL
abnormal	NULL
up-regulation	NULL
of	NULL
the	NULL
gene	NULL
rather	NULL
than	NULL
the	NULL
down-regulation	NULL
that	NULL
normally	NULL
occurs	NULL
in	NULL
B	NULL
cell	NULL
maturation	NULL
in	NULL
germinal	NULL
centers	NULL
.	NULL

Lower	NULL
protein	NULL
expression	NULL
in	NULL
follicle-center	NULL
B	NULL
cells	NULL
and	NULL
weak	NULL
mRNA	NULL
expression	NULL
in	NULL
circulating	NULL
peripheral-blood	NULL
lymphocytes	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
physiologic	NULL
down-regulation	NULL
of	NULL
TCL1	NULL
from	NULL
the	NULL
high	NULL
levels	NULL
seen	NULL
in	NULL
quiescent	NULL
mantle-zone	NULL
B	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
AIDS	NULL
IBLP	NULL
may	NULL
originate	NULL
Medical	NULL
Sciences	NULL
:	NULL
Teitell	NULL
et	NULL
al	NULL
.	NULL

from	NULL
the	NULL
rare	NULL
intensely	NULL
stained	NULL
interfollicular-zone	NULL
cells	NULL
that	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
TCL1	NULL
protein	NULL
.	NULL

AIDS	NULL
lymphomas	NULL
develop	NULL
under	NULL
unique	NULL
and	NULL
extreme	NULL
pathological	NULL
conditions	NULL
.	NULL

These	NULL
include	NULL
moderate	NULL
to	NULL
severe	NULL
immu-nodeficiency	NULL
,	NULL
chronic	NULL
antigenic	NULL
stimulation	NULL
,	NULL
profound	NULL
alterations	NULL
of	NULL
cytokine	NULL
expression	NULL
profiles	NULL
,	NULL
and	NULL
the	NULL
loss	NULL
of	NULL
normal	NULL
lymph-node	NULL
architecture	NULL
because	NULL
of	NULL
progressive	NULL
immune	NULL
system	NULL
destruction	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

1-3	NULL
,	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
abundant	NULL
TCLI	NULL
expression	NULL
in	NULL
AIDS	NULL
lymphoma	NULL
results	NULL
from	NULL
the	NULL
radically	NULL
altered	NULL
cytokine	NULL
profiles	NULL
in	NULL
AIDS	NULL
or	NULL
from	NULL
the	NULL
absence	NULL
of	NULL
critical	NULL
cell-mediated	NULL
regulatory	NULL
influences	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
such	NULL
as	NULL
those	NULL
provided	NULL
by	NULL
DRC	NULL
or	NULL
T	NULL
cells	NULL
)	NULL
that	NULL
occur	NULL
in	NULL
normal	NULL
lymph	NULL
nodes	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
these	NULL
cell-mediated	NULL
regulatory	NULL
influences	NULL
may	NULL
also	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
widely	NULL
varying	NULL
levels	NULL
of	NULL
TCL1	NULL
expression	NULL
seen	NULL
in	NULL
multiple	NULL
B	NULL
cell	NULL
tumor	NULL
lines	NULL
.	NULL

Resolution	NULL
of	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
controlling	NULL
expression	NULL
in	NULL
AIDS	NULL
lymphoma	NULL
versus	NULL
normal	NULL
developing	NULL
B	NULL
cells	NULL
will	NULL
provide	NULL
important	NULL
insights	NULL
into	NULL
the	NULL
contribution	NULL
of	NULL
TCLI	NULL
expression	NULL
in	NULL
AIDS	NULL
lymphomagenesis	NULL
.	NULL

Unchecked	NULL
,	NULL
high-level	NULL
expression	NULL
is	NULL
reported	NULL
to	NULL
cause	NULL
early	NULL
polyclonal	NULL
,	NULL
proliferative	NULL
T	NULL
cell	NULL
expansions	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
findings	NULL
presented	NULL
here	NULL
strongly	NULL
suggest	NULL
that	NULL
elevated	NULL
TCL1	NULL
expression	NULL
also	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
an	NULL
abnormal	NULL
cellular	NULL
regulatory	NULL
program	NULL
that	NULL
creates	NULL
an	NULL
equivalent	NULL
,	NULL
early	NULL
,	NULL
or	NULL
premalignant	NULL
lymphoproliferative	NULL
state	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Subsequent	NULL
transforming	NULL
events	NULL
,	NULL
such	NULL
as	NULL
p53	NULL
mutations	NULL
,	NULL
c-MYC	NULL
rearrangements	NULL
,	NULL
or	NULL
other	NULL
genetic	NULL
alterations	NULL
could	NULL
then	NULL
promote	NULL
frank	NULL
B	NULL
cell	NULL
tumor	NULL
formation	NULL
,	NULL
in	NULL
analogy	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
introducing	NULL
c-MYC	NULL
mutations	NULL
into	NULL
BCL-2	NULL
transgenic	NULL
mice	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

65	NULL
and	NULL
66	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
Michael	NULL
Lee	NULL
for	NULL
excellent	NULL
technical	NULL
support	NULL
and	NULL
members	NULL
of	NULL
the	NULL
Teitell	NULL
,	NULL
Denny	NULL
,	NULL
and	NULL
Wall	NULL
laboratories	NULL
for	NULL
insightful	NULL
discussions	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
C.	NULL
Malone	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
UCLA	NULL
Jonsson	NULL
Comprehensive	NULL
Cancer	NULL
Foundation	NULL
,	NULL
Amgen/U.C	NULL
.	NULL

BioStar	NULL
Program	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
CA74929	NULL
,	NULL
CA66533	NULL
,	NULL
and	NULL
GM40185	NULL
)	NULL
and	NULL
the	NULL
Lymphoma	NULL
Research	NULL
Foundation	NULL
of	NULL
America	NULL
(	NULL
012127	NULL
)	NULL
.	NULL

M.T	NULL
.	NULL

is	NULL
a	NULL
LRFA	NULL
Fellow	NULL
.	NULL

We	NULL
also	NULL
specifically	NULL
acknowledge	NULL
the	NULL
generous	NULL
support	NULL
and	NULL
encouragement	NULL
of	NULL
Dr.	NULL
L.	NULL
Souza	NULL
(	NULL
Amgen	NULL
)	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Hamilton-Dutoit	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Pallesen	NULL
,	NULL
G.	NULL
,	NULL
Franzmann	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Karkov	NULL
,	NULL
J.	NULL
,	NULL
Black	NULL
,	NULL
F.	NULL
,	NULL
Skinhoj	NULL
,	NULL
P.	NULL
&	NULL
Pedersen	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

138	NULL
,	NULL
149-163	NULL
.	NULL

2	NULL
.	NULL

Raphael	NULL
,	NULL
M.	NULL
,	NULL
Gentilhomme	NULL
,	NULL
O.	NULL
,	NULL
Tulliez	NULL
,	NULL
M.	NULL
,	NULL
Byron	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Diebold	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Arch	NULL
.	NULL

Pathol	NULL
.	NULL

Lab	NULL
.	NULL

Med	NULL
.	NULL

115	NULL
,	NULL
15-20	NULL
.	NULL

3	NULL
.	NULL

Raphael	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Audouin	NULL
,	NULL
J.	NULL
,	NULL
Lamine	NULL
,	NULL
M.	NULL
,	NULL
Delecluse	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Vuillaume	NULL
,	NULL
M.	NULL
,	NULL
Lenoir	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Gisselbrecht	NULL
,	NULL
C.	NULL
,	NULL
Lennert	NULL
,	NULL
K.	NULL
&	NULL
Diebold	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Pathol	NULL
.	NULL

101	NULL
,	NULL
773-782	NULL
.	NULL

4	NULL
.	NULL

Herndier	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Kaplan	NULL
,	NULL
L.	NULL
D.	NULL
&	NULL
McGrath	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
AIDS	NULL
8	NULL
,	NULL
1025-1049	NULL
.	NULL

5	NULL
.	NULL

Diebold	NULL
,	NULL
J.	NULL
,	NULL
Raphael	NULL
,	NULL
M.	NULL
,	NULL
Prevot	NULL
,	NULL
S.	NULL
&	NULL
Audouin	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Cancer	NULL
Surv	NULL
.	NULL

30	NULL
,	NULL
263-293	NULL
.	NULL

6	NULL
.	NULL

Knowles	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Semin	NULL
.	NULL

Diagn	NULL
.	NULL

Pathol	NULL
.	NULL

14	NULL
,	NULL
67-82	NULL
.	NULL

7	NULL
.	NULL

Gaidano	NULL
,	NULL
G.	NULL
,	NULL
Carbone	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

152	NULL
,	NULL
623-630	NULL
.	NULL

8	NULL
.	NULL

Jaffe	NULL
,	NULL
E.	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Pathol	NULL
.	NULL

105	NULL
,	NULL
141-143	NULL
.	NULL

9	NULL
.	NULL

Carbone	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Gaidano	NULL
,	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

97	NULL
,	NULL
515-522	NULL
.	NULL

10	NULL
.	NULL

_	NULL
Cesarman	NULL
,	NULL
E.	NULL
&	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Semin	NULL
.	NULL

Diagn	NULL
.	NULL

Pathol	NULL
.	NULL

14	NULL
,	NULL
54-66	NULL
.	NULL

11	NULL
.	NULL

Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Jhanwar	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Koziner	NULL
,	NULL
B.	NULL
,	NULL
Arlin	NULL
,	NULL
Z.	NULL
,	NULL
Mertels-mann	NULL
,	NULL
R.	NULL
&	NULL
Clarkson	NULL
,	NULL
B.	NULL
D.	NULL
(	NULL
1983	NULL
)	NULL
Blood	NULL
61	NULL
,	NULL
1265-1268	NULL
.	NULL

12	NULL
.	NULL

Groopman	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Sullivan	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Mulder	NULL
,	NULL
C.	NULL
,	NULL
Ginsburg	NULL
,	NULL
D.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
O'Hara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Falchuk	NULL
,	NULL
K.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
&	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
67	NULL
,	NULL
612-615	NULL
.	NULL

13	NULL
.	NULL

Subar	NULL
,	NULL
M.	NULL
,	NULL
Neri	NULL
,	NULL
A.	NULL
,	NULL
Inghirami	NULL
,	NULL
G.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
667-671	NULL
.	NULL

14	NULL
.	NULL

Ballerini	NULL
,	NULL
P.	NULL
,	NULL
Gaidano	NULL
,	NULL
G.	NULL
,	NULL
Gong	NULL
,	NULL
J	NULL
.	NULL

Z.	NULL
,	NULL
Tassi	NULL
,	NULL
V.	NULL
,	NULL
Saglio	NULL
,	NULL
G.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
166-176	NULL
.	NULL

15	NULL
.	NULL

Gaidano	NULL
,	NULL
G.	NULL
,	NULL
Parsa	NULL
,	NULL
N.	NULL
Z.	NULL
,	NULL
Tassi	NULL
,	NULL
V.	NULL
,	NULL
Della-Latta	NULL
,	NULL
P.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Leukemia	NULL
7	NULL
,	NULL
1621-1629	NULL
.	NULL

16	NULL
.	NULL

Cesarman	NULL
,	NULL
E.	NULL
,	NULL
Chang	NULL
,	NULL
Y.	NULL
,	NULL
Moore	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Said	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

332	NULL
,	NULL
1186-1191	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
9813	NULL
Carbone	NULL
,	NULL
A.	NULL
,	NULL
Gloghini	NULL
,	NULL
A.	NULL
,	NULL
Vaccher	NULL
,	NULL
E.	NULL
,	NULL
Zagonel	NULL
,	NULL
V.	NULL
,	NULL
Pastore	NULL
,	NULL
C.	NULL
,	NULL
Dalla	NULL
Palma	NULL
,	NULL
P.	NULL
,	NULL
Branz	NULL
,	NULL
F.	NULL
,	NULL
Saglio	NULL
,	NULL
G.	NULL
,	NULL
Volpe	NULL
,	NULL
R.	NULL
,	NULL
Tirelli	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Gaidano	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

94	NULL
,	NULL
533-543	NULL
.	NULL

Gaidano	NULL
,	NULL
G.	NULL
,	NULL
Pastore	NULL
,	NULL
C.	NULL
,	NULL
Gloghini	NULL
,	NULL
A.	NULL
,	NULL
Cusini	NULL
,	NULL
M.	NULL
,	NULL
Nomdedeu	NULL
,	NULL
J.	NULL
,	NULL
Volpe	NULL
,	NULL
G.	NULL
,	NULL
Capello	NULL
,	NULL
D.	NULL
,	NULL
Vaccher	NULL
,	NULL
E.	NULL
,	NULL
Bordes	NULL
,	NULL
R.	NULL
,	NULL
Tirelli	NULL
,	NULL
U.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
AIDS	NULL
10	NULL
,	NULL
941-949	NULL
.	NULL

Nador	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Cesarman	NULL
,	NULL
E.	NULL
,	NULL
Chadburn	NULL
,	NULL
A.	NULL
,	NULL
Dawson	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Ansari	NULL
,	NULL
M.	NULL
Q.	NULL
,	NULL
Sald	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
88	NULL
,	NULL
645-656	NULL
.	NULL

Lyons	NULL
,	NULL
S.	NULL
F.	NULL
&	NULL
Liebowitz	NULL
,	NULL
D.	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Semin	NULL
.	NULL

Oncol	NULL
.	NULL

25	NULL
,	NULL
461-475	NULL
.	NULL

Hsi	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
Foreman	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Duggan	NULL
,	NULL
J.	NULL
,	NULL
Alkan	NULL
,	NULL
S.	NULL
,	NULL
Kauffman	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Aronow	NULL
,	NULL
H.	NULL
D.	NULL
&	NULL
Nickoloff	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Surg	NULL
.	NULL

Pathol	NULL
.	NULL

22	NULL
,	NULL
493-499	NULL
.	NULL

Delecluse	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Raphael	NULL
,	NULL
M.	NULL
,	NULL
Magaud	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Felman	NULL
,	NULL
P.	NULL
,	NULL
Alsamad	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
,	NULL
Bornkamm	NULL
,	NULL
G.	NULL
W.	NULL
&	NULL
Lenoir	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
552-563	NULL
.	NULL

Shiramizu	NULL
,	NULL
B.	NULL
,	NULL
Herndier	NULL
,	NULL
B.	NULL
,	NULL
Meeker	NULL
,	NULL
T.	NULL
,	NULL
Kaplan	NULL
,	NULL
L.	NULL
&	NULL
McGrath	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Oncol	NULL
.	NULL

10	NULL
,	NULL
383-389	NULL
.	NULL

Shibata	NULL
,	NULL
D.	NULL
,	NULL
Weiss	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Hernandez	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Nathwani	NULL
,	NULL
B.	NULL
N.	NULL
,	NULL
Bernstein	NULL
,	NULL
L.	NULL
&	NULL
Levine	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
2102-2109	NULL
.	NULL

Beral	NULL
,	NULL
V.	NULL
,	NULL
Peterman	NULL
,	NULL
T.	NULL
,	NULL
Berkelman	NULL
,	NULL
R.	NULL
&	NULL
Jaffe	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Lancet	NULL
337	NULL
,	NULL
805-809	NULL
.	NULL

Schulz	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
Boshoff	NULL
,	NULL
C.	NULL
H.	NULL
&	NULL
Weiss	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Lancet	NULL
348	NULL
,	NULL
587-591	NULL
.	NULL

Knowles	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Chamulak	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Subar	NULL
,	NULL
M.	NULL
,	NULL
Burke	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Dugan	NULL
,	NULL
M.	NULL
,	NULL
Wernz	NULL
,	NULL
J.	NULL
,	NULL
Slywotzky	NULL
,	NULL
C.	NULL
,	NULL
Pelicci	NULL
,	NULL
G.	NULL
,	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
&	NULL
Raphael	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

108	NULL
,	NULL
744-753	NULL
.	NULL

Gaidano	NULL
,	NULL
G.	NULL
&	NULL
Carbone	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

90	NULL
,	NULL
235-243	NULL
.	NULL

Carbone	NULL
,	NULL
A.	NULL
,	NULL
Gaidano	NULL
,	NULL
G.	NULL
,	NULL
Gloghini	NULL
,	NULL
A.	NULL
,	NULL
Larocca	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Capello	NULL
,	NULL
D.	NULL
,	NULL
Canzonieri	NULL
,	NULL
V.	NULL
,	NULL
Antinori	NULL
,	NULL
A.	NULL
,	NULL
Tirelli	NULL
,	NULL
U.	NULL
,	NULL
Falini	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Blood	NULL
91	NULL
,	NULL
747-755	NULL
.	NULL

Gaidano	NULL
,	NULL
G.	NULL
,	NULL
Carbone	NULL
,	NULL
A.	NULL
,	NULL
Pastore	NULL
,	NULL
C.	NULL
,	NULL
Capello	NULL
,	NULL
D.	NULL
,	NULL
Migliazza	NULL
,	NULL
A.	NULL
,	NULL
Gloghini	NULL
,	NULL
A.	NULL
,	NULL
Roncella	NULL
,	NULL
S.	NULL
,	NULL
Ferrarini	NULL
,	NULL
M.	NULL
,	NULL
Saglio	NULL
,	NULL
G.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
89	NULL
,	NULL
3755-3762	NULL
.	NULL

Gaidano	NULL
,	NULL
G.	NULL
,	NULL
Lo	NULL
Coco	NULL
,	NULL
F.	NULL
,	NULL
Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Shibata	NULL
,	NULL
D.	NULL
,	NULL
Levine	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
397-402	NULL
.	NULL

Ganser	NULL
,	NULL
A.	NULL
,	NULL
Carlo-Stella	NULL
,	NULL
C.	NULL
,	NULL
Bartram	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Boehm	NULL
,	NULL
T.	NULL
,	NULL
Heil	NULL
,	NULL
G.	NULL
,	NULL
Henglein	NULL
,	NULL
B.	NULL
,	NULL
Muller	NULL
,	NULL
H.	NULL
,	NULL
Raghavachar	NULL
,	NULL
A.	NULL
,	NULL
von	NULL
Briesen	NULL
,	NULL
H.	NULL
,	NULL
Griesinger	NULL
,	NULL
F.	NULL
,	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
1255-1260	NULL
.	NULL

Diatchenko	NULL
,	NULL
L.	NULL
,	NULL
Lau	NULL
,	NULL
Y.	NULL
F.	NULL
,	NULL
Campbell	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Chenchik	NULL
,	NULL
A.	NULL
,	NULL
Mogadam	NULL
,	NULL
F.	NULL
,	NULL
Huang	NULL
,	NULL
B.	NULL
,	NULL
Lukyanov	NULL
,	NULL
S.	NULL
,	NULL
Lukyanov	NULL
,	NULL
K.	NULL
,	NULL
Gurskaya	NULL
,	NULL
N.	NULL
,	NULL
Sverdlov	NULL
,	NULL
E.	NULL
D.	NULL
&	NULL
Siebert	NULL
,	NULL
P.	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
6025-6030	NULL
.	NULL

Peterson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Brown	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Carlisle	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Kohn	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Liotta	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Emmert-Buck	NULL
,	NULL
M.	NULL
R.	NULL
&	NULL
Krizman	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

58	NULL
,	NULL
5326-5328	NULL
.	NULL

Russo	NULL
,	NULL
G.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Pegoraro	NULL
,	NULL
L.	NULL
,	NULL
Finan	NULL
,	NULL
J.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
137-144	NULL
.	NULL

Mengle-Gaw	NULL
,	NULL
L.	NULL
,	NULL
Albertson	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Sherrington	NULL
,	NULL
P.	NULL
D.	NULL
&	NULL
Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
9171-9175	NULL
.	NULL

Davey	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Bertness	NULL
,	NULL
V.	NULL
,	NULL
Nakahara	NULL
,	NULL
K.	NULL
,	NULL
Johnson	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
McBride	NULL
,	NULL
O.	NULL
W.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Kirsch	NULL
,	NULL
I.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
9287-9291	NULL
.	NULL

Virgilio	NULL
,	NULL
L.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Narducci	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Carotenuto	NULL
,	NULL
P.	NULL
,	NULL
Cam-erini	NULL
,	NULL
B.	NULL
,	NULL
Kurosawa	NULL
,	NULL
N.	NULL
,	NULL
Abbas	NULL
ar	NULL
,	NULL
R.	NULL
,	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Russo	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
9275-9279	NULL
.	NULL

Narducci	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Virgilio	NULL
,	NULL
L.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Stoppacciaro	NULL
,	NULL
A.	NULL
,	NULL
Elli	NULL
,	NULL
R.	NULL
,	NULL
Fiorilli	NULL
,	NULL
M.	NULL
,	NULL
Carbonari	NULL
,	NULL
M.	NULL
,	NULL
Antonelli	NULL
,	NULL
A.	NULL
,	NULL
Chessa	NULL
,	NULL
L.	NULL
,	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
2358-2364	NULL
.	NULL

Virgilio	NULL
,	NULL
L.	NULL
,	NULL
Narducci	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Billips	NULL
,	NULL
L.	NULL
G.	NULL
,	NULL
Cooper	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Russo	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
12530-4	NULL
.	NULL

Takizawa	NULL
,	NULL
J.	NULL
,	NULL
Suzuki	NULL
,	NULL
R.	NULL
,	NULL
Kuroda	NULL
,	NULL
H.	NULL
,	NULL
Utsunomiya	NULL
,	NULL
A.	NULL
,	NULL
Kagami	NULL
,	NULL
Y.	NULL
,	NULL
Joh	NULL
,	NULL
T.	NULL
,	NULL
Aizawa	NULL
,	NULL
Y.	NULL
,	NULL
Ueda	NULL
,	NULL
R.	NULL
&	NULL
Seto	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

89	NULL
,	NULL
712-718	NULL
.	NULL

Pekarsky	NULL
,	NULL
Y.	NULL
,	NULL
Hallas	NULL
,	NULL
C.	NULL
,	NULL
Isobe	NULL
,	NULL
M.	NULL
,	NULL
Russo	NULL
,	NULL
G.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
,	NULL
2949-2951	NULL
.	NULL

Said	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Sassoon	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Shintaku	NULL
,	NULL
I.	NULL
P.	NULL
,	NULL
Corcoran	NULL
,	NULL
P.	NULL
&	NULL
Nichols	NULL
,	NULL
S.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Mod	NULL
.	NULL

Pathol	NULL
.	NULL

3	NULL
,	NULL
659-663	NULL
.	NULL

Nakamura	NULL
,	NULL
H.	NULL
,	NULL
Said	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Miller	NULL
,	NULL
C.	NULL
W.	NULL
&	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
920-926	NULL
.	NULL

Lones	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Mishalani	NULL
,	NULL
S.	NULL
,	NULL
Shintaku	NULL
,	NULL
I.	NULL
P.	NULL
,	NULL
Weiss	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Nichols	NULL
,	NULL
W.	NULL
S.	NULL
&	NULL
Said	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Hum	NULL
.	NULL

Pathol	NULL
.	NULL

26	NULL
,	NULL
525-530	NULL
.	NULL

Said	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Rettig	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Heppner	NULL
,	NULL
K.	NULL
,	NULL
Vescio	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Schiller	NULL
,	NULL
G.	NULL
,	NULL
Ma	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Belson	NULL
,	NULL
D.	NULL
,	NULL
Savage	NULL
,	NULL
A.	NULL
,	NULL
Shintaku	NULL
,	NULL
I.	NULL
P.	NULL
,	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
4278-4282	NULL
.	NULL

9814	NULL
47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Teitell	NULL
et	NULL
al	NULL
.	NULL

Said	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Pinkus	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Yamashita	NULL
,	NULL
J.	NULL
,	NULL
Mishalani	NULL
,	NULL
S.	NULL
,	NULL
Matsumura	NULL
,	NULL
F.	NULL
,	NULL
Yamashiro	NULL
,	NULL
S.	NULL
&	NULL
Pinkus	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
Mod	NULL
.	NULL

Pathol	NULL
.	NULL

10	NULL
,	NULL
421-427	NULL
.	NULL

Said	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Pinkus	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Shintaku	NULL
,	NULL
I.	NULL
P.	NULL
,	NULL
deVos	NULL
,	NULL
S.	NULL
,	NULL
Matsumura	NULL
,	NULL
F.	NULL
,	NULL
Yamashiro	NULL
,	NULL
S.	NULL
&	NULL
Pinkus	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Mod	NULL
.	NULL

Pathol	NULL
.	NULL

11	NULL
,	NULL
1-5	NULL
.	NULL

Pelicci	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
d.	NULL
,	NULL
Arlin	NULL
,	NULL
Z	NULL
.	NULL

A.	NULL
,	NULL
Wieczorek	NULL
,	NULL
R.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
,	NULL
Dina	NULL
,	NULL
D.	NULL
,	NULL
Basilico	NULL
,	NULL
C.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164	NULL
,	NULL
2049-2060	NULL
.	NULL

Legler	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Loetscher	NULL
,	NULL
M.	NULL
,	NULL
Roos	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Clark-Lewis	NULL
,	NULL
L	NULL
,	NULL
Baggiolini	NULL
,	NULL
M.	NULL
&	NULL
Moser	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
,	NULL
655-660	NULL
.	NULL

Gunn	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Ngo	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
Ansel	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ekland	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Cyster	NULL
,	NULL
J.	NULL
G.	NULL
&	NULL
Williams	NULL
,	NULL
L.	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
391	NULL
,	NULL
799-803	NULL
.	NULL

Fu	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Virgilio	NULL
,	NULL
L.	NULL
,	NULL
Narduceci	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Facchiano	NULL
,	NULL
A.	NULL
,	NULL
Russo	NULL
,	NULL
G.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

54	NULL
,	NULL
6297-6301	NULL
.	NULL

Madani	NULL
,	NULL
A.	NULL
,	NULL
Choukroun	NULL
,	NULL
V.	NULL
,	NULL
Soulier	NULL
,	NULL
J.	NULL
,	NULL
Cacheux	NULL
,	NULL
V.	NULL
,	NULL
Claisse	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Valensi	NULL
,	NULL
F.	NULL
,	NULL
Daliphard	NULL
,	NULL
S.	NULL
,	NULL
Cazin	NULL
,	NULL
B.	NULL
,	NULL
Levy	NULL
,	NULL
V.	NULL
,	NULL
Leblond	NULL
,	NULL
V.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
1923-1927	NULL
.	NULL

Stern	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Soulier	NULL
,	NULL
J.	NULL
,	NULL
Rosenzwajg	NULL
,	NULL
M.	NULL
,	NULL
Nakahara	NULL
,	NULL
K.	NULL
,	NULL
Canki-Klain	NULL
,	NULL
N.	NULL
,	NULL
Aurias	NULL
,	NULL
A.	NULL
,	NULL
Sigaux	NULL
,	NULL
F.	NULL
&	NULL
Kirsch	NULL
,	NULL
I.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
2475-2483	NULL
.	NULL

Hoh	NULL
,	NULL
F.	NULL
,	NULL
Yang	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
Guignard	NULL
,	NULL
L.	NULL
,	NULL
Padilla	NULL
,	NULL
A.	NULL
,	NULL
Stern	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Lhoste	NULL
,	NULL
J.	NULL
M.	NULL
&	NULL
van	NULL
Tilbeurgh	NULL
,	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Structure	NULL
(	NULL
London	NULL
)	NULL
6	NULL
,	NULL
147-155	NULL
.	NULL

Kuppers	NULL
,	NULL
R.	NULL
,	NULL
Zhao	NULL
,	NULL
M.	NULL
,	NULL
Hansmann	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Rajewsky	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
4955-4967	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
Hummel	NULL
,	NULL
M.	NULL
,	NULL
Tamaru	NULL
,	NULL
J.	NULL
,	NULL
Kalvelage	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Stein	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
403-407	NULL
.	NULL

MacLennan	NULL
,	NULL
I.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
117-139	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
J	NULL
.	NULL

&	NULL
Arpin	NULL
,	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

156	NULL
,	NULL
111-126	NULL
.	NULL

Pezzella	NULL
,	NULL
F.	NULL
,	NULL
Tse	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Cordell	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Pulford	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Gatter	NULL
,	NULL
K.	NULL
C.	NULL
&	NULL
Mason	NULL
,	NULL
D.	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

137	NULL
,	NULL
225-232	NULL
.	NULL

Chleq-Deschamps	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
LeBrun	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Huie	NULL
,	NULL
P.	NULL
,	NULL
Besnier	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Warnke	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Sibley	NULL
,	NULL
R.	NULL
K.	NULL
&	NULL
Cleary	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
293-298	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
Mason	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
Johnson	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Abbot	NULL
,	NULL
S.	NULL
,	NULL
Gregory	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Hardie	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Gordon	NULL
,	NULL
J	NULL
.	NULL

&	NULL
MacLennan	NULL
,	NULL
I.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Fur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21	NULL
,	NULL
1905-1910	NULL
.	NULL

Virgilio	NULL
,	NULL
L.	NULL
,	NULL
Lazzeri	NULL
,	NULL
C.	NULL
,	NULL
Bichi	NULL
,	NULL
R.	NULL
,	NULL
Nibu	NULL
,	NULL
K.	NULL
,	NULL
Narducci	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Russo	NULL
,	NULL
G.	NULL
,	NULL
Rothstein	NULL
,	NULL
J.	NULL
L.	NULL
&	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
,	NULL
3885-3889	NULL
.	NULL

Gritti	NULL
,	NULL
C.	NULL
,	NULL
Dastot	NULL
,	NULL
H.	NULL
,	NULL
Soulier	NULL
,	NULL
J.	NULL
,	NULL
Janin	NULL
,	NULL
A.	NULL
,	NULL
Daniel	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Madani	NULL
,	NULL
A.	NULL
,	NULL
Grimber	NULL
,	NULL
G.	NULL
,	NULL
Briand	NULL
,	NULL
P.	NULL
,	NULL
Sigaux	NULL
,	NULL
F.	NULL
&	NULL
Stern	NULL
,	NULL
M.	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Blood	NULL
92	NULL
,	NULL
368-373	NULL
.	NULL

Cory	NULL
,	NULL
S.	NULL
,	NULL
Vaux	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Strasser	NULL
,	NULL
A.	NULL
,	NULL
Harris	NULL
,	NULL
A.	NULL
W.	NULL
&	NULL
Adams	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

59	NULL
,	NULL
1685s-1692s	NULL
.	NULL

Korsmeyer	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

59	NULL
,	NULL
1693s-1700s	NULL
.	NULL

Levitt	NULL
,	NULL
R.	NULL
,	NULL
Pierre	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
White	NULL
,	NULL
W.	NULL
L.	NULL
&	NULL
Sickert	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1978	NULL
)	NULL
Blood	NULL
52	NULL
,	NULL
1003-1011	NULL
.	NULL

